{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+for+prednisolone&page=4", "query": { "intervention": "Placebo for prednisolone", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 90, "total_pages": 9, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+for+prednisolone&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+for+prednisolone&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-04T18:05:24.955Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00806208", "title": "Trial for Evaluation of Safety of Escalating Dose Levels of MEDI-507 in Patients for Treatment of at Least Grade II Graft-Versus-Host Disease (GvHD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Graft-Versus-Host Disease" ], "interventions": [ { "name": "MEDI-507", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 34, "start_date": "1999-01", "completion_date": "2000-03", "has_results": false, "last_update_posted_date": "2008-12-11", "last_synced_at": "2026-10-04T18:05:24.955Z", "location_count": 3, "location_summary": "St Louis, Missouri • Omaha, Nebraska • Dallas, Texas", "locations": [ { "city": "St Louis", "state": "Missouri" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00806208" }, { "nct_id": "NCT02309385", "title": "Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Non-Infectious Anterior Uveitis" ], "interventions": [ { "name": "8% Dexamethasone Sodium Phosphate - Visulex", "type": "DRUG" }, { "name": "15% Dexamethasone Sodium Phosphate - Visulex", "type": "DRUG" }, { "name": "Prednisolone Acetate (1%) Eye Drops", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aciont Inc", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 44, "start_date": "2014-10", "completion_date": "2017-03-03", "has_results": false, "last_update_posted_date": "2017-04-27", "last_synced_at": "2026-10-04T18:05:24.955Z", "location_count": 6, "location_summary": "Cambridge, Massachusetts • Charlotte, North Carolina • Fargo, North Dakota + 3 more", "locations": [ { "city": "Cambridge", "state": "Massachusetts" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Fargo", "state": "North Dakota" }, { "city": "Austin", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02309385" }, { "nct_id": "NCT03298061", "title": "Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Churg-Strauss Syndrome", "Eosinophilic Granulomatosis With Polyangiitis" ], "interventions": [ { "name": "Mepolizumab", "type": "DRUG" }, { "name": "Prednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2015-04-14", "completion_date": "2023-02-16", "has_results": true, "last_update_posted_date": "2024-03-12", "last_synced_at": "2026-10-04T18:05:24.955Z", "location_count": 14, "location_summary": "Denver, Colorado • Bethesda, Maryland • Boston, Massachusetts + 10 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03298061" }, { "nct_id": "NCT05113901", "title": "Medrol Dosepak Taper for Delayed Post-op Recovery After TKA", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Total Knee Arthroplasty" ], "interventions": [ { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rush University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2022-03-03", "completion_date": "2022-07-25", "has_results": true, "last_update_posted_date": "2023-10-23", "last_synced_at": "2026-10-04T18:05:24.955Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05113901" }, { "nct_id": "NCT06670521", "title": "Corticosteroids for Post-Extubation Dysphagia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dysphagia", "Laryngeal Edema" ], "interventions": [ { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Normal Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2024-12-02", "completion_date": "2027-05-31", "has_results": false, "last_update_posted_date": "2026-05-06", "last_synced_at": "2026-10-04T18:05:24.955Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06670521" }, { "nct_id": "NCT04738318", "title": "Steroid Administration for Articular Fractures of the Elbow (SAFE Trial)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Elbow Fracture" ], "interventions": [ { "name": "Glucocorticoids", "type": "DRUG" }, { "name": "Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2022-06-16", "completion_date": "2023-03-10", "has_results": true, "last_update_posted_date": "2023-12-29", "last_synced_at": "2026-10-04T18:05:24.955Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04738318" }, { "nct_id": "NCT02872597", "title": "Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Status Asthmaticus" ], "interventions": [ { "name": "Ipratropium", "type": "DRUG" }, { "name": "0.9% Sodium Chloride", "type": "DRUG" }, { "name": "Albuterol", "type": "DRUG" }, { "name": "corticosteroids", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University Hospitals Cleveland Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 30, "start_date": "2016-09-05", "completion_date": "2018-08-16", "has_results": false, "last_update_posted_date": "2019-04-18", "last_synced_at": "2026-10-04T18:05:24.955Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02872597" }, { "nct_id": "NCT01995513", "title": "Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Enzalutamide", "type": "DRUG" }, { "name": "Abiraterone", "type": "DRUG" }, { "name": "Placebo for Enzalutamide", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 509, "start_date": "2013-10-22", "completion_date": "2022-08-31", "has_results": true, "last_update_posted_date": "2023-09-18", "last_synced_at": "2026-10-04T18:05:24.955Z", "location_count": 6, "location_summary": "Boston, Massachusetts • Philadelphia, Pennsylvania • Virginia Beach, Virginia", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01995513" }, { "nct_id": "NCT01272635", "title": "Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma", "Wheezing" ], "interventions": [ { "name": "Azithromycin", "type": "DRUG" }, { "name": "Prednisolone", "type": "DRUG" }, { "name": "Placebo Azithromycin", "type": "OTHER" }, { "name": "Placebo Prednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Months", "maximum_age": "71 Months", "sex": "ALL", "summary": "12 Months to 71 Months" }, "enrollment_count": 607, "start_date": "2011-03", "completion_date": "2015-01", "has_results": true, "last_update_posted_date": "2016-12-28", "last_synced_at": "2026-10-04T18:05:24.955Z", "location_count": 16, "location_summary": "Tucson, Arizona • Oakland, California • San Francisco, California + 11 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Oakland", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01272635" }, { "nct_id": "NCT04221477", "title": "A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lupus Nephritis" ], "interventions": [ { "name": "Obinutuzumab", "type": "DRUG" }, { "name": "MMF", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 271, "start_date": "2020-08-10", "completion_date": "2031-03-02", "has_results": true, "last_update_posted_date": "2026-07-21", "last_synced_at": "2026-10-04T18:05:24.955Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Beverly Hills, California • Fontana, California + 14 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Fontana", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04221477" } ] }